Our results demonstrate that naïve HD patients without previous SARS-CoV-2 infection (Figure 4A) exhibit a significant increase in IFN-ɣ and IL-2 production 20 days after the second vaccine dose (d40), in comparison with HV. The gene discussed is IL2; the disease is Huntington disease.